Page last updated: 2024-08-22

diallyl trisulfide and Carcinoma, Squamous Cell

diallyl trisulfide has been researched along with Carcinoma, Squamous Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, Q; Li, S; Wang, F; Wang, L; Zong, H	1

Other Studies

1 other study(ies) available for diallyl trisulfide and Carcinoma, Squamous Cell

Article	Year
DATS suppresses growth of esophageal squamous cell carcinoma by regulation of ERK1/2. Clinical laboratory, 2015, Volume: 61, Issue:3-4 Topics: Allyl Compounds; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Proto-Oncogene Proteins c-akt; Sulfides	2015

Article

Year

DATS suppresses growth of esophageal squamous cell carcinoma by regulation of ERK1/2.

Clinical laboratory, 2015, Volume: 61, Issue:3-4

Topics: Allyl Compounds; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Proto-Oncogene Proteins c-akt; Sulfides

2015